VOLT-02

VOLT-02 is a water-soluble conjugate of progesterone and a neurosteroid which is under development by Levolta Pharmaceuticals (formerly Voltarra Pharmaceuticals) for the treatment of traumatic brain injury, gynecological disorders, and menstrual disorders.^[1] As of March 2017, it is in phase II clinical trials for these indications.^[1] The chemical structure of VOLT-02 does not appear to have been released yet.^[1]

VOLT-02

Clinical data
Other names	Progesterone conjugate
Drug class	Progestogen; Neurosteroid
Identifiers
CAS Number	2763338-59-4

See also

• List of neurosteroids § Inhibitory > Synthetic > Pregnanes
• List of progestogen esters § Oximes of progesterone derivatives
• List of investigational sex-hormonal agents § Progestogenics